INVESTABOT
Equity Research
XNAS · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
TL;DR: MiMedx posted Q1 2026 revenue of $59 million, down 33.1% from $88.2 million in the year-ago quarter, as sweeping Medicare reimbursement changes hit the wound care market hard.
open-market Form 4 only - grants, exercises, tax withholding excluded
0 buyers - 0 unique sellers · 9 accumulating - 4 trimming - 0 unchanged
| Institution | Shares | Value ($) | Change % | Filing date |
|---|---|---|---|---|
| BlackRock | 11,333,771 | ~$76.7M | — | February 12, 2026 |
| BlackRock | 9,313,838 | ~$64.5M | — | August 13, 2024 |
| Vanguard Group | 7,184,262 | ~$48.6M | — | January 29, 2026 |
| BlackRock | 11,911,300 | ~$47.0M | 5.1% | May 13, 2026 |
| BlackRock | 12,154,466 | ~$46.8M | 2.0% | August 7, 2026 |
| State Street | 3,813,796 | ~$25.8M | — | February 13, 2026 |
| State Street | 5,578,920 | ~$21.5M | 10.3% | August 7, 2026 |
| State Street | 5,056,801 | ~$20.0M | 32.6% | May 15, 2026 |
| Renaissance Technologies | 2,467,065 | ~$16.7M | — | February 12, 2026 |
| Renaissance Technologies | 3,019,871 | ~$11.9M | 22.4% | May 14, 2026 |
| Goldman Sachs | 2,665,562 | ~$10.3M | 124.8% | August 14, 2026 |
| AQR Capital | 2,467,005 | ~$9.5M | 170.3% | August 14, 2026 |
| Renaissance Technologies | 2,444,230 | ~$9.4M | -19.1% | August 13, 2026 |
| Goldman Sachs | 1,090,385 | ~$7.4M | — | March 25, 2026 |
| Morgan Stanley | 727,783 | ~$4.9M | — | May 27, 2026 |
| Goldman Sachs | 1,185,561 | ~$4.7M | 8.7% | May 15, 2026 |
| Millennium Management | 619,921 | ~$4.2M | — | February 17, 2026 |
| Morgan Stanley | 1,043,286 | ~$4.0M | 28.4% | August 13, 2026 |
| AQR Capital | 912,728 | ~$3.6M | 123.8% | May 15, 2026 |
| Citadel Advisors | 844,138 | ~$3.2M | 3.9% | August 14, 2026 |